A Study of LY3084077 in Healthy Participants

NCT01846702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: LY3084077

Sponsor

Eli Lilly and Company